๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Assessing the non-cancer risk for RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine) using physiologically based pharmacokinetic (PBPK) modeling

โœ Scribed by Lisa M. Sweeney; Chester P. Gut Jr.; Michael L. Gargas; Gunda Reddy; Larry R. Williams; Mark S. Johnson


Book ID
113965822
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
385 KB
Volume
62
Category
Article
ISSN
0273-2300

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Synthesis of 14C-labelled hexahydro-1,3,
โœ Guy Ampleman; Sonia Thiboutot; J. Lavigne; A. Marois; J. Hawari; A. M. Jones; D. ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 756 KB

## Abstract Within the framework of an R & D project on bioremediation of soils contaminated with energetic compounds, the biodegradation of energetic products such as hexogen (RDX), trinitrotoluene (TNT), nitrocellulose (NC) and glycidyl azide polymer (GAP) is under study. Microcosm assays must be